EGFR and diabetes mellitus: Gilbert et al. evaluated the effects of vorinostat, a histone deacetylase (HDAC) inhibitor, in attenuating the enlargement of the kidneys in diabetics with a focus on the EGF interaction with EGFR (Gilbert et al., 2011).